Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03581825 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of a Reusable Multifocal Optical Design in a Presbyopic Population
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
NCT03581825 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 63 participants.
The verdict
NCT03581825, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
Study Summary
This is a single-masked, randomized-controlled, dispensing clinical trial. A total of approximately 60 eligible myopic subjects will be targeted to complete the study.
Interventions
- DEVICE senofilcon A Multifocal
- DEVICE senofilcon A Sphere
- DEVICE etafilcon A Multifocal
- DEVICE etafilcon A Sphere
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2018-06-08 |
| Est. Completion | 2018-08-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03581825
The ClinicalTrials.gov registry entry for NCT03581825 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which senofilcon A Multifocal is the first listed.
NCT03581825 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03581825 about?
NCT03581825 is a clinical study titled "Clinical Evaluation of a Reusable Multifocal Optical Design in a Presbyopic Population". This is a single-masked, randomized-controlled, dispensing clinical trial. A total of approximately 60 eligible myopic subjects will be targeted to complete the study.
What is the current status of trial NCT03581825?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2018-06-08. Estimated completion is 2018-08-20.
What interventions are being tested in trial NCT03581825?
The interventions under investigation include: senofilcon A Multifocal (DEVICE), senofilcon A Sphere (DEVICE), etafilcon A Multifocal (DEVICE), etafilcon A Sphere (DEVICE).
Who is sponsoring clinical trial NCT03581825?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.